Why Left Bundle Branch Block Develops After Valve Replacement
Left bundle branch block (LBBB) develops after valve replacement due to mechanical compression of the left bundle branch by the prosthetic valve, particularly when the valve is implanted deeply or overlaps with the membranous septum where the conduction system runs along the left ventricular side of the muscular septum. 1
Anatomic Mechanism
The development of LBBB after valve replacement is fundamentally an anatomic problem related to the proximity of the conduction system to the aortic valve apparatus:
The left bundle branch runs along the left ventricular side of the interventricular septum, just beneath the aortic valve annulus, particularly near the commissure between the right and non-coronary cusps 1
The membranous septum is the critical anatomic landmark where the bundle of His penetrates into the left ventricle. When valve prostheses overlap with or compress this region, conduction disturbances occur 1
Unlike surgical AVR (where trauma occurs from decalcification or suture placement near the conduction system), valve replacement—particularly transcatheter approaches—causes conduction abnormalities through direct mechanical impingement of the conduction system by the prosthesis itself 2
Key Risk Factors for Post-Valve Replacement LBBB
Patient-Related Factors:
- Smaller LV outflow tract diameter creates less space between the valve and conduction tissue 1
- Heavy calcification below the non-coronary cusp provides an anatomic substrate for compression near the membranous septum 1
- Increased interventricular septal thickness 2
- Pre-existing conduction abnormalities on baseline ECG 2
- Greater VBR-STJ angle (angle between virtual basal ring and sino-tubular junction) leads to asymmetric valve deployment with deeper implantation below the right coronary cusp 3
Procedural Factors:
- Depth of prosthesis implantation—deeper implantation increases risk by bringing the valve frame closer to the left bundle 1
- Higher prosthesis-to-LV outflow tract diameter ratio 1
- Valve type and profile—larger profile valves (CoreValve 19.2-42.5% vs Sapien 1.8-8.5%) and those extending low into the LVOT carry higher risk 2
- Rapid-deployment and sutureless valves (INTUITY Elite, Perceval) show LBBB rates of 21-23% 4, 5
- Balloon aortic valvuloplasty during the procedure 1
Incidence by Valve Type
The incidence varies dramatically by approach and valve type:
- TAVR: 14-83% develop new LBBB, with 20-30% having persistent LBBB 2, 6
- Surgical AVR (conventional): 4.6% develop new LBBB 7
- Rapid-deployment valves: 21.2% (INTUITY/INTUITY Elite) 4
- Sutureless valves: 23.1% persistent LBBB (Perceval) 5
Timing and Persistence
Most conduction abnormalities occur during the procedure itself: 46% during balloon valvuloplasty, 25% during positioning/wire-crossing, and 29% during prosthesis expansion 2. However, delayed LBBB can occur in approximately 12% of cases, appearing days after the procedure rather than immediately 8.
Clinical Implications and Monitoring
Immediate Concerns:
- Complete heart block risk is higher when LBBB develops, particularly in patients with pre-existing right bundle branch block 2
- Continuous ECG monitoring should be performed for at least 2-7 days post-procedure, especially with new or worsened conduction disturbances (PR or QRS interval increase ≥10%) 1
Long-term Consequences:
- New-onset cardiomyopathy: 27.5% of patients with permanent LBBB develop LVEF <45% at 1 year (vs 2% in controls) 9
- Decreased LVEF: Significant decline in left ventricular function at follow-up (delta -5.7% vs +0.2%) 5
- Permanent pacemaker requirement: 14.5% with persistent LBBB require PPM (vs 6.3% without) 5
- Dysrhythmic events: 12.1% vs 1.4% in controls 4
Important Caveats:
- Some LBBB is transient—approximately 34.9% develop new LBBB initially, but only 23.1% have persistent LBBB at discharge 5
- Mortality impact is unclear—most studies show no significant difference in all-cause or cardiovascular mortality at 1 year, though functional deterioration and heart failure events are more common 7, 4, 5
Post-Discharge Monitoring Strategy
For patients with new or worsened conduction disturbances (PR or QRS ≥10% increase) who don't meet criteria for immediate pacemaker:
- Ambulatory electrocardiographic monitoring (AEM) for at least 14 days post-discharge is recommended 1
- High-degree AV block occurs at median 6 days (range 3-24 days), with 10 of 12 events within 8 days in one study 1
- The monitoring infrastructure must have capacity to respond to high-degree AV block within 1 hour 1